IE
INO icon

Israel Englander’s Inovio Pharmaceuticals INO Stock Holding History

Israel Englander’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,500
Closed -$1.07M – 7082
2021
Q3 		$1.07M Buy
12,500
+4,167
+50% +$418K ﹤0.01% 4597
2021
Q2 		$927K Sell
8,333
-20,609
-71% -$1.98M ﹤0.01% 4733
2021
Q1 		$3.22M Sell
28,942
-225
-0.8% -$29.6K ﹤0.01% 3061
2020
Q4 		$3.1M Buy
+29,167
New +$3.88M ﹤0.01% 2874
2020
Q3 		– Sell
-4,167
Closed -$1.35M – 4623
2020
Q2 		$1.35M Buy
+4,167
New +$669K ﹤0.01% 2808

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Israel Englander's INO Position: Q2 2026 in Review

Israel Englander reduced its Inovio Pharmaceuticals (INO) stake by 44% in Q2 2026, selling an estimated $729K and leaving 796,107 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #4405.

Israel Englander first reported a position in INO in Q1 2014 and has held it in 38 quarters since. The position peaked at $12.6M in Q1 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Israel Englander held 796,107 shares of Inovio Pharmaceuticals worth $876K as of Q2 2026.
  • Israel Englander sold 614,738 Inovio Pharmaceuticals shares in Q2 2026, an estimated $729K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4405 holding.
  • Israel Englander first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 38 quarters since.
  • Israel Englander's Inovio Pharmaceuticals position peaked at $12.6M in Q1 2020.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.